Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
2000 2
2004 2
2006 1
2007 1
2009 5
2010 10
2011 9
2012 17
2013 22
2014 30
2015 22
2016 24
2017 17
2018 9
2019 17
2020 21
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

195 results
Results by year
Filters applied: . Clear all
Page 1
Targeting the bone marrow microenvironment in multiple myeloma.
Kawano Y, Moschetta M, Manier S, Glavey S, Görgün GT, Roccaro AM, Anderson KC, Ghobrial IM. Kawano Y, et al. Among authors: moschetta m. Immunol Rev. 2015 Jan;263(1):160-72. doi: 10.1111/imr.12233. Immunol Rev. 2015. PMID: 25510276 Review.
The Developing Story of Predictive Biomarkers in Colorectal Cancer.
Boussios S, Ozturk MA, Moschetta M, Karathanasi A, Zakynthinakis-Kyriakou N, Katsanos KH, Christodoulou DK, Pavlidis N. Boussios S, et al. Among authors: moschetta m. J Pers Med. 2019 Feb 7;9(1):12. doi: 10.3390/jpm9010012. J Pers Med. 2019. PMID: 30736475 Free PMC article. Review.
Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach.
Boussios S, Karihtala P, Moschetta M, Abson C, Karathanasi A, Zakynthinakis-Kyriakou N, Ryan JE, Sheriff M, Rassy E, Pavlidis N. Boussios S, et al. Among authors: moschetta m. Invest New Drugs. 2020 Feb;38(1):181-193. doi: 10.1007/s10637-019-00867-4. Epub 2019 Oct 24. Invest New Drugs. 2020. PMID: 31650446 Review.
Wise Management of Ovarian Cancer: On the Cutting Edge.
Boussios S, Mikropoulos C, Samartzis E, Karihtala P, Moschetta M, Sheriff M, Karathanasi A, Sadauskaite A, Rassy E, Pavlidis N. Boussios S, et al. Among authors: moschetta m. J Pers Med. 2020 May 21;10(2):41. doi: 10.3390/jpm10020041. J Pers Med. 2020. PMID: 32455595 Free PMC article. Review.
Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.
Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine TH, Manier S, Mishima Y, Murakami N, Bustoros M, Pistofidis RS, Reidy M, Shen YJ, Rahmat M, Lukyanchykov P, Karreci ES, Tsukamoto S, Shi J, Takagi S, Huynh D, Sacco A, Tai YT, Chesi M, Bergsagel PL, Roccaro AM, Azzi J, Ghobrial IM. Kawano Y, et al. Among authors: moschetta m. J Clin Invest. 2018 Jun 1;128(6):2487-2499. doi: 10.1172/JCI88169. Epub 2018 May 14. J Clin Invest. 2018. PMID: 29558366 Free PMC article.
BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population.
Turner NC, Alarcón E, Armstrong AC, Philco M, López Chuken YA, Sablin MP, Tamura K, Gómez Villanueva A, Pérez-Fidalgo JA, Cheung SYA, Corcoran C, Cullberg M, Davies BR, de Bruin EC, Foxley A, Lindemann JPO, Maudsley R, Moschetta M, Outhwaite E, Pass M, Rugman P, Schiavon G, Oliveira M. Turner NC, et al. Among authors: moschetta m. Ann Oncol. 2019 May 1;30(5):774-780. doi: 10.1093/annonc/mdz086. Ann Oncol. 2019. PMID: 30860570 Free PMC article. Clinical Trial.
195 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page